We are live on ! Find out more
PIIIW icon

P3 Health Partners Warrant

40 hedge funds and large institutions have $11.1M invested in P3 Health Partners Warrant in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less funds holding

Funds holding: 45 → 40 (-5)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

49% less capital inflows, than outflows

Capital inflows: $2.18M | Capital outflows: $4.25M

Holders
40
Holders Change
-5
Holders Change %
-11.11%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
8
Closed
18
Calls
$350​K
Puts
–
Net Calls
+$350​K
Net Calls Change
+$59​K

PIIIW Hedge Fund Activity: Q4 2021 in Review

40 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners Warrant (PIIIW) for Q4 2021, worth a combined $11.1M — up 2.7% from $10.8M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PIIIW and 13 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was Ameriprise, opening a new position worth an estimated $599K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.9M sold.

  • 40 institutional investors held P3 Health Partners Warrant (PIIIW) as of Q4 2021, down from 45 in Q3 2021.
  • Funds reported $11.1M of P3 Health Partners Warrant stock for Q4 2021, up 2.7% quarter-over-quarter.
  • 13 funds opened new P3 Health Partners Warrant positions in Q4 2021 and 18 closed out, a net change of -5 holders.
  • The largest P3 Health Partners Warrant buyer in Q4 2021 was Ameriprise, an estimated $599K added.
  • The largest P3 Health Partners Warrant seller in Q4 2021 was Radcliffe Capital Management, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2021.